Search results
Moderna director Noubar Afeyan sells over $2.2m in company stock By Investing.com
Investing.com· 4 hours agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has recently sold a substantial number of shares...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 15 hours agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 13 hours agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 9 hours agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 22 hours agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 12 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 17 hours agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...